erythromycin has been researched along with fluorouracil in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (14.29) | 18.7374 |
1990's | 2 (9.52) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 9 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Doma, MR; Jada, S; Khan, IA; Kumar, HM; Kumar, S; Malik, F; Qazi, GN; Sharma, A; Singh, PP | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Ganesh Kumar, C; Malla Reddy, G; Nagender, P; Naresh Kumar, R; Narsaiah, B; Poornachandra, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Araujo, FG; Huskinson-Mark, J; Remington, JS | 1 |
Amblard, P; Bastrenta, F; Beani, JC; Gautron, R; Harrouch, L; Jardon, P; Reymond, JL | 1 |
Lovett, PS | 1 |
Donnini, C; Marmiroli, N; Puglisi, PP | 1 |
Baker, LH; Griffith, KA; Hayes, DF; Rae, JM; Schott, AF; Sterns, V | 1 |
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
1 review(s) available for erythromycin and fluorouracil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for erythromycin and fluorouracil
Article | Year |
---|---|
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Breast Neoplasms; Breath Tests; Capecitabine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Deoxycytidine; Erythromycin; Female; Fluorouracil; Genotype; Humans; Maximum Tolerated Dose; Middle Aged; Polymorphism, Restriction Fragment Length; Vinblastine; Vinorelbine | 2006 |
19 other study(ies) available for erythromycin and fluorouracil
Article | Year |
---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
Topics: Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Biological Products; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; DNA Fragmentation; Drug Design; Humans; Lignans | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Biofilms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Pyridines; Pyrimidines; Structure-Activity Relationship; Triazoles | 2014 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii.
Topics: Adenine; Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Brain; Clindamycin; Coccidiostats; Erythromycin; Fluorouracil; Mice; Mice, Inbred CBA; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma | 1991 |
Screening for drug photosensitization activity by measuring the variations in oxygen consumption of Bacillus subtilis.
Topics: Aspirin; Bacillus subtilis; Benzoyl Peroxide; Chlorpromazine; Erythromycin; Fluorouracil; Light; Methoxsalen; Oxygen Consumption; Patch Tests; Photosensitivity Disorders; Tretinoin | 1985 |
Spontaneous auxotrophic and pigmented mutants occurring at high frequency in Bacillus pumilus NRRL B-3275.
Topics: Acridines; Alkanesulfonates; Bacillus; Culture Media; Drug Resistance, Microbial; Erythromycin; Fluorouracil; L Forms; Lysogeny; Methylation; Mutagens; Mutation; Nitrosoguanidines; Pigments, Biological; Rifampin; Spectrophotometry; Streptomycin; Sulfates; Temperature; Transduction, Genetic; Tryptophan | 1972 |
The role of the nuclear gene "mitochondrial mutability control" (MMC1) in the process of mutability of the mitochondrial genome by different mutagens in Saccharomyces cerevisiae.
Topics: Acriflavine; Cell Nucleus; Diminazene; DNA, Fungal; DNA, Mitochondrial; Erythromycin; Ethidium; Fluorouracil; Gene Expression Regulation; Manganese; Mutagens; Rosaniline Dyes; Saccharomyces cerevisiae | 1983 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |